As Rainbow Coral Corp. (OTCBB:RBCC) continues its due diligence on Nano3D Biosciences (n3D), it's not just the early-stage biotech firm's groundbreaking technology that has impressed RBCCâ€”It's also n3D's revenues.
â€œWe continue to be impressed by n3D in our due diligence and look forward to closing the transactionâ€
"Nano3D's revolutionary Bio-Assembler system is already being commercially produced and sold," said RBCC CEO Patrick Brown. "That's rare for an early-stage company like n3D, and it makes the company very attractive. It fits our model target in this spaceâ€”early-stage and close to or already commercial.
"We continue to be impressed by n3D in our due diligence and look forward to closing the transaction," he added.
The Bio-Assembler system enables scientists to grow and study cells in a three-dimensional environment more easily than ever before, making research on stem cells and other tissues dramatically faster and more affordable.
Source Rainbow BioSciences